Amiotrófiás laterálszklerózis (ALS): vizsgálatok itt: Spanyolország
15 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 14.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleStudy is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
- Where
- L'hospitalet De Llobregat, Valencia
- Életkor
- 18 év and over
- People
- 36 worldwide
- Run by
- Vector Y Therapeutics
See details and how to joinNCT07287397 · EU 2025-522697-37-00 - 1. fázisTaking peopleA Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
- Where
- L'hospitalet De Llobregat, Valencia
- Életkor
- 18 év to 75 év
- People
- 36 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07100119 · EU 2025-521295-60-00 - 3. fázisTaking peoplePridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- Where
- Barcelona, Madrid, Santiago de Compostela, Valencia
- Életkor
- 18 év to 80 év
- People
- 500 worldwide
- Run by
- Prilenia
See details and how to joinNCT07322003 - 1. fázisTaking peopleA Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
- Where
- L'Hospitalet de Llobregat, Valencia
- Életkor
- 18 év to 80 év
- People
- 32 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07571174 - 1. fázisTaking peopleA Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)
- Where
- L'hospitalet De Llobregat, Valencia
- Életkor
- 18 év to 80 év
- People
- 32 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07571200 · EU 2026-525574-19-00 - 2. fázisTaking peopleUsnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
- Where
- Alicante, L'hospitalet De Llobregat, Málaga, Valencia
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Zydus Therapeutics Inc.
See details and how to joinNCT07023835 · EU 2025-522580-15-00 - No phaseNot yet taking people in SpanyolországDeveloping a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients
- Where
- Barcelona
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- University Hospital, Montpellier
See details and how to joinNCT07737977 - 2. fázisTaking peoplePHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
- Where
- Alicante, Barcelona, Madrid, Málaga, Seville
- Életkor
- 18 év to 75 év
- People
- 105 worldwide
- Run by
- PhenoNet, Inc.
See details and how to joinNCT07142291 - 3. fázisTaking peoplePridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
- Where
- Barcelona, L'hospitalet De Llobregat, Madrid, Santiago de Compostela, Valencia
- Életkor
- 18 év and over
- People
- 420 worldwide
- Run by
- Ferrer Internacional S.A.
See details and how to join2025-524002-16-00 - No phaseTaking peopleInspiratory Muscle Training in Amiotrophyc Lateral Sclerosis
- Where
- Donostia / San Sebastian
- Életkor
- 18 év to 85 év
- People
- 44
- Run by
- University Ramon Llull
See details and how to joinNCT07413718 - 1/2. fázisTaking peopleEvaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)
- Where
- Donostia
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Biogipuzkoa Health Research Institute
See details and how to joinNCT07414212 · EU 2024-519857-13-00 - 3. fázisNot yet taking people in SpanyolországEfficacy and Safety of Masitinib in Combination With SoC Versus Placebo in the Treatment of ALS Patients
- Where
- Barcelona
- Életkor
- 18 év to 80 év
- People
- 412 worldwide
- Run by
- AB Science
See details and how to joinNCT07174492 · EU 2024-511244-12-01 - 3. fázisTaking peopleEfficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Where
- Alicante, Barcelona, Madrid, Santiago de Compostela, Valencia
- Életkor
- 18 év to 81 év
- People
- 495 worldwide
- Run by
- AB Science
See details and how to joinNCT03127267 - No phaseTaking peopleTesting Pulse Stimulation to Improve Motor Function in People With ALS: A Pilot Study
- Where
- Barcelona
- Életkor
- 21 év to 80 év
- People
- 50
- Run by
- Parc de Salut Mar
See details and how to joinNCT06681610 - 2. fázisTaking peopleClinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis (TCIM-ELAII)
- Where
- Alicante, Murcia
- Életkor
- 18 év and over
- People
- 100
- Run by
- Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia
See details and how to joinNCT04849065 · EU 2023-506215-17-00